These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 32183090)

  • 1. Exploratory Analysis of iPSCS-Derived Neuronal Cells as Predictors of Diagnosis and Treatment of Alzheimer Disease.
    Cavalli E; Battaglia G; Basile MS; Bruno V; Petralia MC; Lombardo SD; Pennisi M; Kalfin R; Tancheva L; Fagone P; Nicoletti F; Mangano K
    Brain Sci; 2020 Mar; 10(3):. PubMed ID: 32183090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induced pluripotent stem cell-derived neuronal cells from a sporadic Alzheimer's disease donor as a model for investigating AD-associated gene regulatory networks.
    Hossini AM; Megges M; Prigione A; Lichtner B; Toliat MR; Wruck W; Schröter F; Nuernberg P; Kroll H; Makrantonaki E; Zouboulis CC; Adjaye J
    BMC Genomics; 2015 Feb; 16(1):84. PubMed ID: 25765079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathological manifestation of the induced pluripotent stem cell-derived cortical neurons from an early-onset Alzheimer's disease patient carrying a presenilin-1 mutation (S170F).
    Li L; Kim HJ; Roh JH; Kim M; Koh W; Kim Y; Heo H; Chung J; Nakanishi M; Yoon T; Hong CP; Seo SW; Na DL; Song J
    Cell Prolif; 2020 Apr; 53(4):e12798. PubMed ID: 32216003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A simplified and sensitive method to identify Alzheimer's disease biomarker candidates using patient-derived induced pluripotent stem cells (iPSCs).
    Shirotani K; Matsuo K; Ohtsuki S; Masuda T; Asai M; Kutoku Y; Ohsawa Y; Sunada Y; Kondo T; Inoue H; Iwata N
    J Biochem; 2017 Dec; 162(6):391-394. PubMed ID: 28992104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-Analysis of Transcriptome Data Related to Hippocampus Biopsies and iPSC-Derived Neuronal Cells from Alzheimer's Disease Patients Reveals an Association with FOXA1 and FOXA2 Gene Regulatory Networks.
    Wruck W; Schröter F; Adjaye J
    J Alzheimers Dis; 2016; 50(4):1065-82. PubMed ID: 26890743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Three-Dimensional Alzheimer's Disease Cell Culture Model Using iPSC-Derived Neurons Carrying A246E Mutation in PSEN1.
    Hernández-Sapiéns MA; Reza-Zaldívar EE; Cevallos RR; Márquez-Aguirre AL; Gazarian K; Canales-Aguirre AA
    Front Cell Neurosci; 2020; 14():151. PubMed ID: 32655369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiomics Identification of Potential Targets for Alzheimer Disease and Antrocin as a Therapeutic Candidate.
    Wu ATH; Lawal B; Wei L; Wen YT; Tzeng DTW; Lo WC
    Pharmaceutics; 2021 Sep; 13(10):. PubMed ID: 34683848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene Expression Studies on Human Trisomy 21 iPSCs and Neurons: Towards Mechanisms Underlying Down's Syndrome and Early Alzheimer's Disease-Like Pathologies.
    Weick JP; Kang H; Bonadurer GF; Bhattacharyya A
    Methods Mol Biol; 2016; 1303():247-65. PubMed ID: 26235072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early pathogenic event of Alzheimer's disease documented in iPSCs from patients with PSEN1 mutations.
    Yang J; Zhao H; Ma Y; Shi G; Song J; Tang Y; Li S; Li T; Liu N; Tang F; Gu J; Zhang L; Zhang Z; Zhang X; Jin Y; Le W
    Oncotarget; 2017 Jan; 8(5):7900-7913. PubMed ID: 27926491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurons derived from sporadic Alzheimer's disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation.
    Ochalek A; Mihalik B; Avci HX; Chandrasekaran A; Téglási A; Bock I; Giudice ML; Táncos Z; Molnár K; László L; Nielsen JE; Holst B; Freude K; Hyttel P; Kobolák J; Dinnyés A
    Alzheimers Res Ther; 2017 Dec; 9(1):90. PubMed ID: 29191219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computational Analysis of Pathogenetic Pathways in Alzheimer's Disease and Prediction of Potential Therapeutic Drugs.
    Petralia MC; Mangano K; Quattropani MC; Lenzo V; Nicoletti F; Fagone P
    Brain Sci; 2022 Jun; 12(7):. PubMed ID: 35884634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human Pluripotent Stem Cells as In Vitro Models of Neurodegenerative Diseases.
    Machairaki V
    Adv Exp Med Biol; 2020; 1195():93-94. PubMed ID: 32468463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Modeling familial Alzheimer's disease with induced pluripotent stem cells].
    Yagi T; Ito D; Okada Y; Akamatsu W; Nihei Y; Okano H; Suzuki N
    Rinsho Shinkeigaku; 2012; 52(11):1134-6. PubMed ID: 23196540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. REST and Neural Gene Network Dysregulation in iPSC Models of Alzheimer's Disease.
    Meyer K; Feldman HM; Lu T; Drake D; Lim ET; Ling KH; Bishop NA; Pan Y; Seo J; Lin YT; Su SC; Church GM; Tsai LH; Yankner BA
    Cell Rep; 2019 Jan; 26(5):1112-1127.e9. PubMed ID: 30699343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induced pluripotent stem cells in Alzheimer's disease: applications for disease modeling and cell-replacement therapy.
    Yang J; Li S; He XB; Cheng C; Le W
    Mol Neurodegener; 2016 May; 11(1):39. PubMed ID: 27184028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased susceptibility to Aβ toxicity in neuronal cultures derived from familial Alzheimer's disease (PSEN1-A246E) induced pluripotent stem cells.
    Armijo E; Gonzalez C; Shahnawaz M; Flores A; Davis B; Soto C
    Neurosci Lett; 2017 Feb; 639():74-81. PubMed ID: 28034781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repurposed Drugs as Potential Therapeutic Candidates for the Management of Alzheimer's Disease.
    Shoaib M; Kamal MA; Rizvi SMD
    Curr Drug Metab; 2017; 18(9):842-852. PubMed ID: 28595531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-butylidenephthalide attenuates Alzheimer's disease-like cytopathy in Down syndrome induced pluripotent stem cell-derived neurons.
    Chang CY; Chen SM; Lu HE; Lai SM; Lai PS; Shen PW; Chen PY; Shen CI; Harn HJ; Lin SZ; Hwang SM; Su HL
    Sci Rep; 2015 Mar; 5():8744. PubMed ID: 25735452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated analysis of differential gene expression profiles in hippocampi to identify candidate genes involved in Alzheimer's disease.
    Hu W; Lin X; Chen K
    Mol Med Rep; 2015 Nov; 12(5):6679-87. PubMed ID: 26324066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alzheimer's disease master regulators analysis: search for potential molecular targets and drug repositioning candidates.
    Vargas DM; De Bastiani MA; Zimmer ER; Klamt F
    Alzheimers Res Ther; 2018 Jun; 10(1):59. PubMed ID: 29935546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.